Enrollment Matters: The Reality of Disparity and Pursuit of Equity in Clinical Trials
Open Access
- 2 June 2022
- journal article
- editorial
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
- Vol. 12 (6) , 1419-1422
Abstract
Summary: Disparities in clinical trial enrollment persist, fortified by the foundation and historical ideologies undergirding clinical cancer research. The scientific community has an ethical responsibility to seize the current moment to deconstruct and reconstruct these paradigms for more equitable research.Keywords
This publication has 12 references indexed in Scilit:
- Diversity and Inclusion in Pancreatic Cancer Clinical TrialsGastroenterology, 2021
- Access Denied: Inequities in Clinical Trial Enrollment for Pancreatic CancerAnnals of Surgical Oncology, 2021
- ASO Author Reflections: Seizing the Momentum to Diversify Cancer Clinical Trial EnrollmentAnnals of Surgical Oncology, 2021
- The Ethical Imperative of Equity in Oncology: Lessons Learned From 2020 and a Path ForwardAmerican Society of Clinical Oncology Educational Book, 2021
- Minority Enrollment to Clinical Trials: Road to Increased AccessONCOLOGY, 2021
- Racial and Ethnic Disparities Among Participants in US-Based Phase 3 Randomized Cancer Clinical TrialsJNCI Cancer Spectrum, 2020
- Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018JAMA Oncology, 2019
- Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 YearsJournal of Oncology Practice, 2018
- Aiming High — Changing the Trajectory for CancerNew England Journal of Medicine, 2016
- The Health and Physique of the Negro AmericanAmerican Journal of Public Health, 2003